Effects of phosphodiesterase inhibitors on interleukin-4 and interleukin-13 generation from human basophils

Br J Pharmacol. 2004 Aug;142(8):1265-72. doi: 10.1038/sj.bjp.0705892. Epub 2004 Jul 20.

Abstract

The aim of the present study was to determine whether inhibition of cyclic nucleotide phosphodiesterase (PDE) modulates the stimulated generation of the cytokines, interleukin-4 (IL-4) and IL-13, from human basophils. This was addressed by evaluating the effects of both nonselective and selective inhibitors of PDEs on the generation of cytokines from basophils. The nonselective PDE inhibitors, isobutyl-methylxanthine (IBMX) and theophylline, attenuated the IgE-mediated generation of IL-4 and IL-13 and, also, the release of histamine from basophils. The effects of the isoform-selective inhibitors, 8-methoxymethyl-IBMX (PDE 1 inhibitor), siguazodan (PDE3 inhibitor), rolipram (PDE4 inhibitor), denbufylline (PDE4 inhibitor), Org 30029 (mixed PDE3 and 4 inhibitor) and zaprinast (PDE5 inhibitor), were studied. Of these selective compounds, only rolipram, denbufylline and Org 30029 inhibited the IgE-dependent generation of IL-4, IL-13 and histamine from basophils to a statistically significant (P<0.05) degree. The effects of isoform-selective inhibitors on basophils activated by IL-3 were evaluated. The IL-3-induced generation of IL-4, IL-13 and histamine was inhibited to a statistically significant (P<0.05) extent, only by compounds that act as inhibitors of PDE4. These data suggest that inhibition of PDE4 can regulate the generation of cytokines from human basophils.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Basophils / drug effects*
  • Basophils / enzymology*
  • Basophils / metabolism
  • Dose-Response Relationship, Drug
  • Humans
  • Interleukin-13 / antagonists & inhibitors
  • Interleukin-13 / biosynthesis*
  • Interleukin-4 / antagonists & inhibitors
  • Interleukin-4 / biosynthesis*
  • Phosphodiesterase Inhibitors / pharmacology*

Substances

  • Interleukin-13
  • Phosphodiesterase Inhibitors
  • Interleukin-4